Biological response modifiers for the treatment of superficial bladder tumors

European Urology

Volumn 37, Issue SUPPL. 3, 2000, Pages 10-15

  Zlotta, Alexandre R ^a   Schulman, Claude C ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

BCG; Biological response modifiers; Bladder cancer; Immunotherapy

Indexed keywords

ALPHA INTERFERON; BCG VACCINE; BIOLOGICAL RESPONSE MODIFIER; CYTOKINE; GARLIC EXTRACT; IMMUNOMODULATING AGENT; INTERLEUKIN 2; KEYHOLE LIMPET HEMOCYANIN; LEVAMISOLE; PICIBANIL; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT BETA INTERFERON; RECOMBINANT GAMMA INTERFERON; RETINOL;

BLADDER CANCER; CLINICAL TRIAL; CONFERENCE PAPER; CYTOKINE RELEASE; DRUG EFFICACY; DRUG SCREENING; DRUG TOXICITY; GENETIC ENGINEERING; HUMAN; IMMUNE RESPONSE; META ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; TRANSITIONAL CELL CARCINOMA;

EID: 0034019058     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052387     Document Type: Conference Paper

References (47)